Call Options

23 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Sep 21, 2023

SELL
$134.21 - $153.93 $38.9 Million - $44.6 Million
-289,600 Reduced 90.61%
30,000 $4.03 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $38.9 Million - $44.6 Million
-289,600 Reduced 90.61%
30,000 $4.03 Million
Q2 2022

Sep 21, 2023

BUY
$137.62 - $174.96 $41.3 Million - $52.5 Million
300,300 Added 1555.96%
319,600 $48.9 Million
Q2 2022

Aug 15, 2022

BUY
$137.62 - $174.96 $41.3 Million - $52.5 Million
300,300 Added 1555.96%
319,600 $49 Million
Q4 2021

Sep 21, 2023

SELL
$107.43 - $135.93 $655,323 - $829,173
-6,100 Reduced 24.02%
19,300 $2.61 Million
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $655,323 - $829,173
-6,100 Reduced 24.02%
19,300 $2.61 Million
Q3 2021

Sep 21, 2023

BUY
$106.4 - $120.78 $2.69 Million - $3.06 Million
25,300 Added 25300.0%
25,400 $2.74 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $2.69 Million - $3.06 Million
25,300 Added 25300.0%
25,400 $2.74 Million
Q2 2021

Sep 21, 2023

SELL
$105.21 - $117.21 $3.15 Million - $3.5 Million
-29,900 Reduced 99.67%
100 $11,000
Q2 2021

Aug 20, 2021

SELL
$105.21 - $117.21 $1.04 Million - $1.16 Million
-9,900 Reduced 99.0%
100 $11,000
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $1.02 Million - $1.14 Million
-9,700 Reduced 49.24%
10,000 $11,000
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $10.8 Million - $14.5 Million
-147,600 Reduced 88.22%
19,700 $1.93 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $7.57 Million - $11.5 Million
-117,300 Reduced 41.22%
167,300 $12.7 Million
Q4 2019

Feb 13, 2020

SELL
$72.13 - $90.25 $10.8 Million - $13.5 Million
-150,000 Reduced 34.51%
284,600 $25.2 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $9.88 Million - $11.9 Million
-156,900 Reduced 26.53%
434,600 $32.9 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $35 Million - $44.8 Million
533,400 Added 918.07%
591,500 $43 Million
Q1 2019

May 15, 2019

SELL
$77.14 - $90.79 $4.59 Million - $5.4 Million
-59,500 Reduced 50.6%
58,100 $4.68 Million
Q4 2018

Feb 14, 2019

BUY
$77.85 - $96.01 $5.75 Million - $7.09 Million
73,800 Added 168.49%
117,600 $10.8 Million
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $631,261 - $701,764
7,100 Added 19.35%
43,800 $4.14 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $15.9 Million - $18.8 Million
-177,000 Reduced 82.83%
36,700 $3.4 Million
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $8.8 Million - $11.8 Million
95,600 Added 80.95%
213,700 $20.2 Million
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $6.4 Million - $7.02 Million
-71,500 Reduced 37.71%
118,100 $11.4 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $13.2 Million - $16.9 Million
189,600
189,600 $16.8 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $302B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.